When assessing information about any treatment, consider the quality of the underlying clinical evidence rather than individual reported experiences, and seek a face-to-face consultation with a qualified doctor before making any decisions
In a recent observational study, individuals who discontinued semaglutide or tirzepatide within the first three months lost only 3.6% of their body weight, while those who quit between three and twelve months lost 6.8%
A few growing pains, but great value once youre in
Published data (STEP 4 trial, JAMA 2022) show that most patients regain a portion of lost weight after discontinuation
What is correctly referred to as CJC-1295 without DAC in research and commercial contexts is therefore Modified GRF (1-29)
Obestatin binds to GRP 39, a receptor of the same subfamily than ghrelin receptor, to decrease food intake and body weight in an opposite manner to ghrelin (Stengel et al., 2009